J.M. Navarro

2.7k total citations
19 papers, 1.4k citations indexed

About

J.M. Navarro is a scholar working on Epidemiology, Pharmacology and Hepatology. According to data from OpenAlex, J.M. Navarro has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Pharmacology and 8 papers in Hepatology. Recurrent topics in J.M. Navarro's work include Drug-Induced Hepatotoxicity and Protection (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (6 papers). J.M. Navarro is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (6 papers). J.M. Navarro collaborates with scholars based in Spain, United States and Australia. J.M. Navarro's co-authors include Raúl J. Andrade, Manuel Romero‐Gómez, M. Isabel Lucena, Javier Salmerón, Luı́s Rodrigo, Miren García‐Cortés, Mercedes Robles‐Díaz, Gloria Isabel Carvajal Peláez, M. Carmen Fernández and Y. Borraz and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

J.M. Navarro

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.M. Navarro Spain	14	693	451	406	257	224	19	1.4k
M Biour France	18	496 0.7×	261 0.6×	164 0.4×	178 0.7×	209 0.9×	80	1.4k
Karin Dilger Germany	21	272 0.4×	371 0.8×	223 0.5×	288 1.1×	123 0.5×	36	1.1k
Ángeles Pizarro Spain	7	691 1.0×	388 0.9×	190 0.5×	240 0.9×	62 0.3×	11	1.1k
Christian Frenzel Germany	28	810 1.2×	397 0.9×	389 1.0×	187 0.7×	72 0.3×	50	1.8k
Mercedes Robles‐Díaz Spain	20	1.2k 1.7×	561 1.2×	416 1.0×	409 1.6×	113 0.5×	63	1.8k
Michael Becka Germany	25	263 0.4×	968 2.1×	694 1.7×	116 0.5×	84 0.4×	51	5.2k
G Babany France	21	488 0.7×	405 0.9×	460 1.1×	220 0.9×	144 0.6×	56	1.3k
Fernando Bessone Argentina	23	662 1.0×	1.4k 3.0×	1.0k 2.5×	225 0.9×	122 0.5×	80	2.3k
Miren García‐Cortés Spain	18	1.3k 1.9×	465 1.0×	340 0.8×	378 1.5×	135 0.6×	55	1.8k
Axel Eickhoff Germany	29	927 1.3×	295 0.7×	148 0.4×	498 1.9×	77 0.3×	75	2.2k

Countries citing papers authored by J.M. Navarro

Since Specialization

Citations

This map shows the geographic impact of J.M. Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Navarro more than expected).

Fields of papers citing papers by J.M. Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Navarro. The network helps show where J.M. Navarro may publish in the future.

Co-authorship network of co-authors of J.M. Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Navarro. A scholar is included among the top collaborators of J.M. Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Navarro. J.M. Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Robles‐Díaz, Mercedes, Miren García‐Cortés, Inmaculada Medina‐Cáliz, et al.. (2015). The value of serum aspartate aminotransferase and gamma‐glutamyl transpetidase as biomarkers in hepatotoxicity. Liver International. 35(11). 2474–2482. 56 indexed citations

Medina‐Cáliz, Inmaculada, J.M. Navarro, Gloria Isabel Carvajal Peláez, et al.. (2014). Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.. PubMed. 106(4). 246–54. 53 indexed citations

Gállego, Javier, et al.. (2014). Colorectal Cancer Surgery in Extreme Elderly Population. Journal of Cancer Therapy. 6(1). 12–20. 1 indexed citations

Calleja, José Luís, J.M. Pascasio, Belén Ruíz‐Antorán, et al.. (2014). Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis. Liver International. 35(1). 90–100. 15 indexed citations

Ampuero, Javier, J.A. Del Campo, José R. García‐Lozano, et al.. (2014). PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C. Annals of Hepatology. 13(4). 356–363. 18 indexed citations

Robles‐Díaz, Mercedes, A. González-Jiménez, Inmaculada Medina‐Cáliz, et al.. (2014). Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Alimentary Pharmacology & Therapeutics. 41(1). 116–125. 87 indexed citations

Fernández‐Rodríguez, Conrado, Rosa M. Morillas, Helena Masnou, et al.. (2013). Randomized clinical trial comparing high versus standard dose of ribavirin plus peginterferon alfa-2a in hepatitis C genotype 3 and high viral load. Dargen-3 study. Gastroenterología y Hepatología. 37(1). 1–8. 2 indexed citations

Ruiz‐Extremera, A., R. Quiles, Ana Belén Barragán Martín, et al.. (2011). Plasma Ribavirin Trough Concentrations During Treatment of Chronic Hepatitis C in Genotype-1 Patients. Journal of Clinical Gastroenterology. 46(4). 328–333. 5 indexed citations

Muñoz-García, Antonio J., Mercedes Robles‐Díaz, Y. Borraz, et al.. (2011). 505 IBUPROFEN-ASSOCIATED HEPATOTOXICITY: ANALYSIS OF A CASE SERIES INCLUDED IN THE SPANISH DILI REGISTRY. Journal of Hepatology. 54. S206–S206. 2 indexed citations

10.

Lucena, M. Isabel, Raúl J. Andrade, Neil Kaplowitz, et al.. (2009). Phenotypic characterization of idiosyncratic drug‐induced liver injury. Hepatology. 49(6). 2001–2009. 227 indexed citations

11.

García‐Cortés, Miren, Y. Borraz, M. Isabel Lucena, et al.. (2008). Hepatotoxicidad secundaria a "productos naturales": análisis de los casos notificados al Registro Español de Hepatotoxicidad. Revista Española de Enfermedades Digestivas. 100(11). 688–95. 67 indexed citations

12.

Pachkoria, Ketevan, M. Isabel Lucena, Francisco Ruiz‐Cabello, et al.. (2008). Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome. Journal of Hepatology. 49(1). 107–114. 59 indexed citations

13.

Romero‐Gómez, Manuel, Emilio Gómez-González, Luı́s Rodrigo, et al.. (2007). Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology. 47(3). 810–816. 45 indexed citations

14.

Lucena, M. Isabel, Raúl J. Andrade, M. Carmen Fernández, et al.. (2006). Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicity. Hepatology. 44(4). 850–856. 110 indexed citations

15.

Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations

16.

Pineda, Juan A., Manuel Romero‐Gómez, J.A. Girón González, et al.. (2005). HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis†. Hepatology. 41(4). 779–789. 212 indexed citations

17.

Lanas, Ángel, María Angeles Pérez-Aisa, Faust Feu, et al.. (2005). A Nationwide Study of Mortality Associated with Hospital Admission Due to Severe Gastrointestinal Events and Those Associated with Nonsteroidal Antiinflammatory Drug Use. The American Journal of Gastroenterology. 100(8). 1685–1693. 267 indexed citations

18.

Andrade, Raúl J., M. Isabel Lucena, Miren García‐Cortés, et al.. (2004). HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology. 39(6). 1603–1612. 108 indexed citations

19.

Romero‐Gómez, Manuel, et al.. (2003). Three‐day intravenous triple therapy is not effective for the eradication of Helicobacter pyloriinfection in patients with bleeding gastro‐duodenal ulcer. Alimentary Pharmacology & Therapeutics. 18(10). 1023–1029. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact